(Date:5/16/2008)...T BEACH, Calif., May 16 /PRNewswire-FirstCall/ -- ...nnounced today the promotion of David,M. Boitano t...cer. "Dave,has made a tremendous contribution to N... strong investment growth and diversification stra... $1 billion in accretive,investments for NHP, leve...
(Date:5/16/2008)...EGO, May 16 /PRNewswire-FirstCall/ -- CryoCor, Inc... on the treatment of cardiac,arrhythmias, announce...f,CryoCor common stock filed a complaint in the Su... San Diego, naming as defendants each member of th...n Scientific Corporation.,The complaint is styled ...
(Date:5/16/2008)...guidelines quickly disseminated to community physi...ealthDay News) -- Partnerships between major acade...uick and effective way to spread cancer treatment ...er in Philadelphia. , Most new cancer treatment...ancer care is provided at community hospitals, not...
(Date:5/16/2008)...ch in some early stage cases makes therapy of litt..., May 16 (HealthDay News) -- Colon cancer patients...to receive chemotherapy. In fact, not only does ch...may actually harm them, a new study found. , "If..., then you should not be treated with chemotherapy...
Breaking Medicine News(10 mins):Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2...itical role in the development of the kidney by ke...ly available to produce the differentiated cells t.../according to investigators at St. Jude Children's...s by which a progenitor (unspecialized) cell devel...
...ish Medical Journal that the ongoing restrictions ... on mythical safety risks, are uncalled for and sh...hospitals after fears of their interference in med...ential confusion between the sound of an alarm fro...
... because you have no family risk of breast cancer,... of women with breast cancer have no family histor...ic Women’s HealthSource offers insights on the ris...cer and ways to reduce risk. Consider: The lifet...
...e federal Department of Health and Human Services ...he initiative, called “Own your future” carries a ...strategies among state residents. Gov Perry while ...n said, “This campaign will focus on encouraging T...
Other Medicine News:Health News:Key Gene Controlling Kidney Development Found 2(Date:5/16/2008)...RK, May 16 /- Pulmo BioTech...details of the methodology and,purpose of its Phas...ing,technology for the diagnosis of Pulmonary Embo...e carried out by the Pulmo BioTech subsidiary,Pul...se I Study of the Use,of PulmoBind for Molecular I...
(Date:5/16/2008)..., Mass., May 16 /- BioVex Inc, a biot...ts in oncology and infectious,disease, announced t...lts,from its Phase II clinical trial of OncoVEX GM...ble at the American Society of Clinical Oncology,(...summary of the abstract,which describes the data a...
(Date:5/16/2008)...N, N.J., May 16 /- Veridex, LLC annou...tory Corporation of America Holdings,(LabCorp), ha...t for,prostate cancer. The new assay uses the biol...e cancer, detecting the methylation of the gene,GS...curs primarily in,cancer. Veridex is developing th...
(Date:5/15/2008)...IFF LAKE, N.J., May 15 /- Eisai Corpo...ts from 16 clinical data abstracts about,compounds...olio and,preclinical oncology research have been a...g of the American Society of Clinical Oncology (AS..., 2008., A wide variety of abstracts on Eisai mar...
Breaking Medicine Technology:Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Ozone Breaks Down Lungs Defenses 2494 1New test could help consumers avoid surprise headaches from chocolate wine 622 1New test could help consumers avoid surprise headaches from chocolate wine 622 2New test could help consumers avoid surprise headaches from chocolate wine 622 3San Diego Dentist Haunted by Smiles in Dominican Republic 2492 1San Diego Dentist Haunted by Smiles in Dominican Republic 2492 2Pure 26 Natural 3A Introducing an Effective Healthy Approach to Personal Care and Beyond 2490 1Pure 26 Natural 3A Introducing an Effective Healthy Approach to Personal Care and Beyond 2490 2Pure 26 Natural 3A Introducing an Effective Healthy Approach to Personal Care and Beyond 2490 3...yer HealthCare,Pharmaceuticals announced today the...R) (interferon beta-1b), presented this week,at th...l Meeting,demonstrating early efficacy, long-term...treatment in patients with relapsing,forms of mult...s highlight the important clinical,benefits and lo...
...e, EDMONTON, May 02, 2007 /PRNewswire-FirstCall/ -...Quest is pleased to provide an,update on the pre-c...prostate cancer. , Prostate cancer is the second l...approximately 230,000 new cases and 30,000 deaths,...ized prostate,cancer are associated with significa...
Other Medicine Technology:Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3Completely revised and updated for 2005, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalog of over 100 drugs
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care.
...s and health consumers from the trusted American S...eatured in MedMaster includes why the medication i...e effects and warning signs of adverse drug reacti... information on what to do if a dose is missed, an...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy.
Medicine Products: